Electrical acupoint stimulation beneficial for heroin addicts

Electrical acupoint stimulation beneficial for heroin addicts

(HealthDay)—Transcutaneous electric acupoint stimulation (TEAS) is associated with alleviation of withdrawal syndrome in heroin addicts, according to a study published in the May issue of Pain Medicine.

Da Ma, M.D., from Peking University in Beijing, and colleagues examined the therapeutic effect of TEAS for the treatment of in 63 male heroin addicts. Participants were randomized to a TEAS group (31 participants), which received TEAS using the Han's Acupoint Nerve Stimulator model 200A with two output channels two to three times per day for 10 days, or a control group (32 participants), which underwent a similar procedure, but the leads of the stimulator output were disconnected.

The researchers found that during heroin detoxification, TEAS treatment alleviated withdrawal syndrome. At the beginning of the observation, there was no significant difference between the groups in withdrawal scores. Starting from the second day, there was a more marked drop in withdrawal scores in the TEAS group versus control; the lower level was maintained for the course of treatment. In the TEAS group, the area under the curve of withdrawal score was only 40 percent of that in the control group, and the buprenorphine requirement was only 10 percent of that in the control group.

"The TEAS therapy is warranted to be validated in larger multicenter clinical trials," the authors write.

One author disclosed inventing the Han's Acupoint Nerve Stimulator device and having financial ties to Jason Scientific, where the product is manufactured.

More information: Abstract
Full Text (subscription or payment may be required)

Copyright © 2015 HealthDay. All rights reserved.

Citation: Electrical acupoint stimulation beneficial for heroin addicts (2015, May 27) retrieved 19 March 2024 from https://medicalxpress.com/news/2015-05-electrical-acupoint-beneficial-heroin-addicts.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Cuts in epilepsy drugs boost children's post-op IQ

10 shares

Feedback to editors